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Volume 51, Number 11S Abstracts 7Sinterposition aortic graft in WT mice. In some mice
Eph-B4 was stimulated with Ephrin-B2/Fc injected IP
every other day until harvest; other vein grafts were locally
treated with WT or mutated Eph-B4 coding adenovirus
(1.0x109 pfu). Vein grafts were harvested and analyzed
after 3-4 weeks.
Results: Stimulation of Eph-B4 with Ephrin-B2/Fc
limited wall thickness (0.03  0.01 mm vs 0.06  0.01
mm, n  5-7). Eph-B4 colocalized with cav-1 in sucrose
gradient separation and co-immunoprecipitation. Vein
grafts derived from cav-1-KO mice had increased wall
thickness (0.09 0.01 mm vs 0.05 0.01 mm, n 3-5).
Unlike WT grafts, Ephrin-B2/Fc treated Cav-1 KO vein
grafts did not have reduced wall thickness (0.09  0.01
mm, n  4). CBD mutated Eph-B4 was unable to phos-
phorylate tyrosine in vitro; adenovirus incorporating the
CBD mutated Eph-B4 did not limit vein graft wall thick-
ness compared to reduced wall thickness with WT Eph-B4
adenovirus (0.09  0.01 mm vs 0.06  0.01 mm, n  6).
Conclusions: Eph-B4 is functional in adult veins and
actively limits vein graft wall thickening during adaptation
to the arterial environment. Caveolin-1 may act as the shear
stress sensor for Eph-B4, suggesting that the Eph-B4-
caveolin-1 pathway may be a therapeutic target to improve
vein graft patency.
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Objectives: To determine the cerebrovascular risk
stratification potential of degree of stenosis, clinical features
and ultrasonic plaque characteristics in patients with asymp-
tomatic internal carotid artery (ICA) stenosis.
Methods: In this prospective, multicentre, cohort
study, 1121 patients with 50-99% asymptomatic ICA ste-
nosis in relation to the bulb (ECST) undergoing medical
intervention were followed-up for 6-98 (mean 48) months.
Hazard ratios for ICA stenosis, clinical features and ultra-
sonic plaque texture features associated with ipsilateral
cerebrovascular or retinal ischemic (CORI) events werecalculated using univariate analysis and Cox proportional
hazard models.
Results: During follow-up, a total of 130 CORI events
including 59 strokes occurred. Severity of stenosis, smok-
ing history of more than 10 pack-years, systolic blood
pressure, history of contralateral TIA or stroke, low gray
scale median (GSM), increased plaque area, plaque types 1,
2 and 3, and presence of discrete white areas without
acoustic shadowing (DWA) were associated with increased
risk. The area under the curve in ROC curves for stenosis,
stenosis combined with clinical features and stenosis com-
bined with clinical features and plaque features was 0.59,
0.66 and 0.82 respectively. In a Cox proportional hazard
model, stenosis, history of contralateral TIA or stroke,
GSM, plaque area and DWA were independent predictors
of stroke. Of the 923 patients with 70 % stenosis ( 50%
NASCET) 5-year stroke rates less than 5%were predicted in
524, 5-9% in 149, 10-19% in 176, 20-29% in 40 and rates
equal or greater than 30% in 34 patients.
Conclusions: Cerebrovascular risk stratification is pos-
sible using a combination of clinical and ultrasonic plaque
features. These finding can be used to refine the indications
for carotid endarterectomy. However, they need to be
validated in additional prospective studies or the medical
arm of future randomized controlled trials of medical vs
surgical or endovascular therapy.
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Objectives: Increasing data are suggesting that statins
can significantly decrease cardiovascular and cerebrovascu-
lar events due to a plaque stabilization effect. However, the
benefit of statins in patients undergoing carotid angioplasty
and stenting (CAS) for carotid stenosis is not well defined.
Aim of this study was to investigate whether statins use was
associated with decreased perioperative and late risks of
stroke, mortality and restenosis in patients undergoing
CAS.
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carotid stenosis from 2003 to 2009 were reviewed. The
independent association of statins and perioperative mor-
bidity was assessed using multivariable analysis. Survival
curves and Cox regression models were used to assess late
morbidity and restenosis.
Results: A total of 1083 consecutive patients were
treated (29% females, mean age71.6y); 464 (43%) patients
were on statin medication before treatment. Statin use was
associated with a reduction of perioperative stroke and
death (HR 0.37; 95% CI 0.14-0.93; p 0.034) and major
stroke rate (HR 0.12; 95% CI 0.016-0.99%; p  0.049)
according to multivariable analysis. Statin effect was more
significant in reducing stroke and death in symptomatic
patients (HR 0.11; 95CI% 0.013-0.95; p  0.045). At 60
months survival (78% vs 82%; p  0.024) and stroke free
interval (p  0.042) rates were higher in statin group of
patients. Adjusting for demographics and comorbidities in
Cox regression analysis, statin use independently reduced
long-term mortality risk (HR 0.6; 95% CI 0.36-0.98; p 
0.043) and borderline decreased the risk of late stroke (HR
0.24; 95% CI 0.053 to 1.09; p 0.06). There was no effect
on restenosis rates.
Conclusions: These data suggest that statin use may
decrease both, perioperative and late stroke and mortality
rates in patients undergoing CAS. Statin therapy should be
considered part of the best medical treatment in current
CAS practice.
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Objectives: Obstructive lesions of the Brachiocephalic
and Subclavian arteries have been traditionally managed
using open surgery, but the advent of endovascular tech-
niques offers a new approach to the management of these
lesions. The aim of our study is to report clinical and
imaging results of a 10-year experience of the endovascular
management of these lesions with evaluation of end-points
at 3-year follow-up.
Methods: A retrospective review of a prospectively
collected data was undertaken of 112 patients (41 women;
mean age 58.9 years, range 36-84) who presented to our
institutions between 1997 and 2006 for endovascular treat-
ment of 141 innominate or subclavian arterial occlusive
lesions. End-points of the study were Primary Patency,Secondary Patency and Blood pressure differential in the
affected limb at 1, 2 and 3 years follow-up.
Results: Initial technical success was achieved in 134
(95.03%) lesions. Primary patency was 97.01% at 1 year,
91.7% at 2 years and 91.5 % at 3 years. Secondary patency
was 98.5% at 1 year, 97.7% at 2 years and 95.5% at 3 years.
A sustained nonrecurrence of symptoms and a BP differen-
tial improvement by 10 mm Hg was observed in 90%
cases at 3 years. Sub-analysis of data for stenotic lesions
revealed that Balloon Angioplasty performed as well as
Stenting. Stenting was superior to Balloon Angioplasty for
total occlusions. There was a complication rate of 7.8%
(2.84% major, 4.96% minor) with an attendant mortality
rate of 0.89%.
Conclusions: In our experience, endovascular inter-
ventions can be accomplished safely with a high degree of
technical success and excellent long-term clinical results
making it an attractive first line treatment for intrathoracic
supraaortic arterial occlusive disease. In addition, we advo-
cate primary stenting for all ostial lesions as well as total
occlusion in this setting.
Author Disclosures: B. Y. Cheung: Nothing to disclose;
K. Ktenidis: Nothing to disclose; R. Tripathi: Nothing to
disclose.
SS10.
Urgent Carotid Endarterectomy in Mild-to-Moderate
Acute Strokes: Preventing Recurrence and Improving
Neurological Outcome
Laura Capoccia1, Enrico Sbarigia1, Francesco Speziale1,
Massimo Ruggiero1, Danilo Toni2, Paolo Fiorani1. 1Vas-
cular Surgery Division, Department of Surgery “P. Stefa-
nini”, Policlinico Umberto I, “Sapienza” University of
Rome, Roma, Italy; 2Stroke Unit, Department of Emer-
gency, Policlinico Umberto I, “Sapienza” University of
Rome, Roma, Italy
Objectives:To evaluate the safety and benefit of urgent
carotid endarterectomy (CEA) in patients with carotid
disease and acute stroke.
Methods: The study involved patients with acute mi-
nor and major strokes related to a carotid stenosis 50%
who underwent urgent CEA. Preoperative workup in-
cluded neurological assessment with National Institute of
Health Stroke Scale (NIHSS) on admission or immediately
before surgery and at discharge, carotid duplex scan, trans-
cranial Doppler ultrasound, head computed tomography
or magnetic resonance imaging. Endpoints were: perioper-
ative (30-day) neurological mortality, NIHSS score im-
provement or worsening (defined as a variation 4), hem-
orrhagic or ischemic stroke recurrence. Patients were
evaluated according to NIHSS score on admission (4-7 or
8), clinical and demographic characteristics, timing of
surgery ( or  6 hours), presence of brain infarction on
neuroimaging. p 0.05 was considered statistically signifi-
cant.
